BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 11071486)

  • 1. Do carbamazepine and phenytoin aggravate juvenile myoclonic epilepsy?
    Genton P; Gelisse P; Thomas P; Dravet C
    Neurology; 2000 Oct; 55(8):1106-9. PubMed ID: 11071486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Worsening of seizures by oxcarbazepine in juvenile idiopathic generalized epilepsies.
    Gelisse P; Genton P; Kuate C; Pesenti A; Baldy-Moulinier M; Crespel A
    Epilepsia; 2004 Oct; 45(10):1282-6. PubMed ID: 15461683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy.
    Thomas P; Valton L; Genton P
    Brain; 2006 May; 129(Pt 5):1281-92. PubMed ID: 16513683
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A; Kuzniecky RI; Knowlton RC; Welty TE; Martin RC; Mendez M; Faught RE
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oxcarbazepine-induced myoclonic status epilepticus in juvenile myoclonic epilepsy.
    Fanella M; Egeo G; Fattouch J; Casciato S; Lapenta L; Morano A; Giallonardo AT; Di Bonaventura C
    Epileptic Disord; 2013 Jun; 15(2):181-7. PubMed ID: 23774821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Case of juvenile myoclonic epilepsy misdiagnosed as simple partial seizure for more than 60 years].
    Mizoi Y; Sumita N; Yamamoto T; Komori T; Tamura N; Shimazu K
    Brain Nerve; 2009 Jan; 61(1):77-81. PubMed ID: 19177810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myoclonic status epilepticus in juvenile myoclonic epilepsy.
    Larch J; Unterberger I; Bauer G; Reichsoellner J; Kuchukhidze G; Trinka E
    Epileptic Disord; 2009 Dec; 11(4):309-14. PubMed ID: 20045780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G; Abou-Khalil B
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged use of phenytoin, carbamazepine or valproate monotherapy on plasma levels of folate and B(12): a comparison between epileptic patients with or without cardiovascular disorders.
    Otoom S; Bakhiet M; Khan A; Sequeira R
    Neuro Endocrinol Lett; 2006; 27(1-2):85-8. PubMed ID: 16648782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Refractory idiopathic absence status epilepticus: A probable paradoxical effect of phenytoin and carbamazepine.
    Osorio I; Reed RC; Peltzer JN
    Epilepsia; 2000 Jul; 41(7):887-94. PubMed ID: 10897162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical factors of drug resistance in juvenile myoclonic epilepsy.
    Gelisse P; Genton P; Thomas P; Rey M; Samuelian JC; Dravet C
    J Neurol Neurosurg Psychiatry; 2001 Feb; 70(2):240-3. PubMed ID: 11160477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability.
    Alvarez N; Besag F; Iivanainen M
    J Intellect Disabil Res; 1998 Dec; 42 Suppl 1():1-15. PubMed ID: 10030426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Juvenile myoclonic epilepsy: diagnosis, management and outcome.
    Sharpe C; Buchanan N
    Med J Aust; 1995 Feb; 162(3):133-4. PubMed ID: 7854224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When antiepileptic drugs aggravate epilepsy.
    Genton P
    Brain Dev; 2000 Mar; 22(2):75-80. PubMed ID: 10722956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
    Hernández-Vanegas LE; Jara-Prado A; Ochoa A; Rodríguez Y Rodríguez N; Durón RM; Crail-Meléndez D; Alonso ME; Delgado-Escueta AV; Martínez-Juárez IE
    Epilepsy Behav; 2016 Aug; 61():34-40. PubMed ID: 27300146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lacosamide treatment of juvenile myoclonic epilepsy.
    Afra P; Adamolekun B
    Seizure; 2012 Apr; 21(3):202-4. PubMed ID: 22281192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inappropriate use of carbamazepine and vigabatrin in typical absence seizures.
    Parker AP; Agathonikou A; Robinson RO; Panayiotopoulos CP
    Dev Med Child Neurol; 1998 Aug; 40(8):517-9. PubMed ID: 9746003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pitfalls in diagnosis of epilepsy of Janz and its implications.
    Jha S; Mathur VN; Mishra VN
    Neurol India; 2002 Dec; 50(4):467-9. PubMed ID: 12577097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate].
    Crespel A; Velizarova R; Genton P; Gélisse P
    Therapie; 2009; 64(5):321-3. PubMed ID: 19863907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing sleep profiles between patients with juvenile myoclonic epilepsy and symptomatic partial epilepsy: Sleep questionnaire-based study.
    Saraswati N; Nayak C; Sinha S; Nagappa M; Thennarasu K; Taly AB
    Epilepsy Behav; 2017 Jan; 66():34-38. PubMed ID: 28012415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.